Çankayalı İ, Boyacılar Ö, Demirağ K, Uyar M, Moral AR. Neuromuscular Dysfunction in Experimental Sepsis and Glutamine.
Balkan Med J 2016;
33:267-74. [PMID:
27308070 DOI:
10.5152/balkanmedj.2016.140483]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2014] [Accepted: 06/26/2015] [Indexed: 01/26/2023] Open
Abstract
BACKGROUND
Electrophysiological studies show that critical illness polyneuromyopathy appears in the early stage of sepsis before the manifestation of clinical findings. The metabolic response observed during sepsis causes glutamine to become a relative essential amino acid.
AIMS
We aimed to assess the changes in neuromuscular transmission in the early stage of sepsis after glutamine supplementation.
STUDY DESIGN
Animal experimentation.
METHODS
Twenty male Sprague-Dawley rats were randomized into two groups. Rats in both groups were given normal feeding for one week. In the study group, 1 g/kg/day glutamine was added to normal feeding by feeding tube for one week. Cecal ligation and perforation (CLP) surgery was performed at the end of one week. Before and 24 hours after CLP, compound muscle action potentials were recorded from the gastrocnemius muscle.
RESULTS
Latency measurements before and 24 hours after CLP were 0.68±0.05 ms and 0.80±0.09 ms in the control group and 0.69±0.07 ms and 0.73±0.07 ms in the study group (p<0.05).
CONCLUSION
Since enteral glutamine prevented compound muscle action potentials (CMAP) latency prolongation in the early phase of sepsis, it was concluded that enteral glutamine replacement might be promising in the prevention of neuromuscular dysfunction in sepsis; however, further studies are required.
Collapse